Abstract | BACKGROUND: METHODS: RESULTS: The 2 treatment groups shared similar baseline characteristics. The median time to platelet engraftment (>20×10(9)/L) and neutrophil engraftment (>0.5×10(9)/L) did not significantly differ between the Z-BuCyE group (12 days and 10 days, respectively) and the BuCyE group (12 days and 10 days, respectively). No significant differences were observed between the groups with respect to toxicities and treatment-related mortality. The median follow-up period was 30.4 months, and median event-free survival was generally better in the Z-BuCyE group (12.5 months) vs. the BuCyE group (6.2 months, P=0.236). No significant difference in overall survival between the groups was noted. CONCLUSION:
|
Authors | Jae-Cheol Jo, Dok Hyun Yoon, Shin Kim, Jung Sun Park, Chan-Sik Park, Jooryung Huh, Sang-Wook Lee, Jin-Sook Ryu, Cheolwon Suh |
Journal | The Korean journal of hematology
(Korean J Hematol)
Vol. 47
Issue 2
Pg. 119-25
(Jun 2012)
ISSN: 2092-9129 [Electronic] Korea (South) |
PMID | 22783358
(Publication Type: Journal Article)
|